Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Liyan Cheng"'
Autor:
Zilin Li, Yiling Xi, Linglan Tu, Xu Zhang, Yue Huang, Huizong Nie, Cheng Peng, Haohuan Chai, Shenxin Zeng, Xiaoliang Zheng, Liyan Cheng
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 173, Iss , Pp 116315- (2024)
Due to resistance and BCR-ABLT315I-mutated, CML remains a clinical challenge. It needs new potential therapeutic targets to overcome CML resistance related to BCR-ABL. Our research revealed that the deubiquitinating enzyme USP28 was highly expressed
Externí odkaz:
https://doaj.org/article/5d6c517a49b24359b2b2d0c0e08ca410
Autor:
Zeng, Shenxin, Huang, Wenhai, Zheng, Xiaoliang, Liyan cheng, Zhang, Zhimin, Wang, Jian, Shen, Zhengrong
Publikováno v:
In European Journal of Medicinal Chemistry 15 January 2021 210
Autor:
Zhenghua Zhang, Yonghe Zhang, Liyan Cheng, Fei Wen, Dan Feng, Feng Zhou, Yu-Hua Shi, Weibing Xu
Publikováno v:
RSC Advances; 2024, Vol. 14 Issue 11, p7910-7914, 5p
Publikováno v:
IEEE Transactions on Neural Networks and Learning Systems. :1-15
This article investigates the finite-time and fixed-time synchronization for memristive neural networks (MNNs) with mixed time-varying delays under the adaptive aperiodically intermittent adjustment strategy. Different from previous works, this artic
Autor:
Yiyi Pu, Dongmei Yan, Linglan Tu, Liyan Cheng, Jie Yu, Zhuduo Li, Xiaoliang Zheng, Xinbao Wang
Publikováno v:
Disease markers. 2022
Background. 5-Fluorouracil (5-FU) has been widely applied in treating cancers. However, its usage is largely limited in hepatocellular carcinoma (HCC), due to acquired resistance. Here, we aim to identify target proteins and investigate their roles i
Autor:
Xu Zhang, Linglan Tu, Haohuan Chai, Zilin Li, Yuhan Fu, Xiaoliang Zheng, Shenxin Zeng, Liyan Cheng
Publikováno v:
Journal of Oncology.
Inducing protein degradation by proteolysis-targeting chimeras (PROTACs) has gained tremendous momentum in the field for its promise in the discovery and development of new therapies. Based on our previously reported PROTAC BCR-ABL degraders, we desi
Publikováno v:
International Journal of Robust and Nonlinear Control. 29:1909-1925
Autor:
Jian Wang, Wenhai Huang, Zhimin Zhang, Zhengrong Shen, Shenxin Zeng, Liyan cheng, Xiaoliang Zheng
Publikováno v:
European journal of medicinal chemistry. 210
Proteolysis targeting chimera (PROTAC), hijacking protein of interest (POI) and recruiting E3 ligase for target degradation via the ubiquitin-proteasome pathway, is a novel drug discovery paradigm which has been widely used as biological tools and me
Publikováno v:
Daxue Huaxue. :2207097
Publikováno v:
Nonlinear Dynamics. 92:1091-1102
The study, by using aperiodically intermittent pinning control, is to synchronize switched delayed complex networks with unstable subsystems. Matrix $$\omega $$ -measure and mode-dependent average dwell time method are used to achieve globally expone